Altimmune, Inc. (ALT)

Altimmune Market Cap

Altimmune has a market cap or net worth of $439.76 million as of April 8, 2026. Its market cap has decreased by -1.20% in one year.

• Market Cap: 439.76M
• Enterprise Value: 201.99M
• 1-Year Change: -1.20%
• Ranking: #3121
• Category: Small-Cap
• Stock Price: $3.38

Market Cap Chart

Since October 6, 2005, Altimmune's market cap has increased from $81.50M to $439.76M, an increase of 439.58%. That is a compound annual growth rate of 8.56%.

Market Cap History

Date	Market Cap	% Change
Apr 6, 2026	433.10M	15.06%
Dec 31, 2025	376.40M	-26.60%
Dec 31, 2024	512.80M	-15.16%
Dec 29, 2023	604.40M	-25.26%
Dec 30, 2022	808.70M	122.17%
Dec 31, 2021	364.00M	-2.41%
Dec 31, 2020	373.00M	1,186.21%
Dec 31, 2019	29.00M	61.11%
Dec 31, 2018	18.00M	-42.12%
Dec 29, 2017	31.10M	-85.66%
Dec 30, 2016	216.90M	77.06%
Dec 31, 2015	122.50M	6.80%
Dec 31, 2014	114.70M	17.88%
Dec 31, 2013	97.30M	79.52%
Dec 31, 2012	54.20M	-11.58%
Dec 30, 2011	61.30M	-64.57%
Dec 31, 2010	173.00M	210.59%
Dec 31, 2009	55.70M	-6.39%
Dec 31, 2008	59.50M	-31.77%
Dec 31, 2007	87.20M	1.04%
Dec 29, 2006	86.30M	4.10%
Dec 30, 2005	82.90M	1.72%
Oct 6, 2005	81.50M	-

View and export this data all the way back to 2005. Sign Up Today.

Related Stocks

Company	Market Cap
ADC Therapeutics	466.25M
Assembly Biosciences	463.51M
Immix Biopharma	454.97M
REGENXBIO	454.19M
Absci	452.94M
Eupraxia Pharmaceuticals	437.01M
Aura Biosciences	428.53M
Lexeo Therapeutics	427.48M